1426 related articles for article (PubMed ID: 16772865)
1. Substance abuse and the management of medication nonadherence in schizophrenia.
Wilk J; Marcus SC; West J; Countis L; Hall R; Regier DA; Olfson M
J Nerv Ment Dis; 2006 Jun; 194(6):454-7. PubMed ID: 16772865
[TBL] [Abstract][Full Text] [Related]
2. Treatment of schizophrenia and comorbid substance abuse: pharmacologic approaches.
Green AI
J Clin Psychiatry; 2006; 67 Suppl 7():31-5; quiz 36-7. PubMed ID: 16961422
[TBL] [Abstract][Full Text] [Related]
3. Schizophrenia and comorbid substance use disorder: effects of antipsychotics.
Green AI
J Clin Psychiatry; 2005; 66 Suppl 6():21-6. PubMed ID: 16107180
[TBL] [Abstract][Full Text] [Related]
4. Review of treatments that can ameliorate nonadherence in patients with schizophrenia.
Kane JM
J Clin Psychiatry; 2006; 67 Suppl 5():9-14. PubMed ID: 16822091
[TBL] [Abstract][Full Text] [Related]
5. [Relationships between insight and medication adherence in subjects with psychosis].
Droulout T; Liraud F; Verdoux H
Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
[TBL] [Abstract][Full Text] [Related]
6. Poison or cure: meanings of medication in schizophrenia.
Rosenfield PJ
J Am Acad Psychoanal Dyn Psychiatry; 2007; 35(2):189-201. PubMed ID: 17650972
[TBL] [Abstract][Full Text] [Related]
7. Management of schizophrenia with substance use disorders.
Lybrand J; Caroff S
Psychiatr Clin North Am; 2009 Dec; 32(4):821-33. PubMed ID: 19944886
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
[TBL] [Abstract][Full Text] [Related]
9. Substance use in persons with schizophrenia: baseline prevalence and correlates from the NIMH CATIE study.
Swartz MS; Wagner HR; Swanson JW; Stroup TS; McEvoy JP; Canive JM; Miller DD; Reimherr F; McGee M; Khan A; Van Dorn R; Rosenheck RA; Lieberman JA
J Nerv Ment Dis; 2006 Mar; 194(3):164-72. PubMed ID: 16534433
[TBL] [Abstract][Full Text] [Related]
10. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
11. Attitudes toward antipsychotic medication: the impact of clinical variables and relationships with health professionals.
Day JC; Bentall RP; Roberts C; Randall F; Rogers A; Cattell D; Healy D; Rae P; Power C
Arch Gen Psychiatry; 2005 Jul; 62(7):717-24. PubMed ID: 15997012
[TBL] [Abstract][Full Text] [Related]
12. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients.
Sokolski KN; Cummings JL; Abrams BI; DeMet EM; Katz LS; Costa JF
J Clin Psychiatry; 1994 Sep; 55(9):380-7. PubMed ID: 7929017
[TBL] [Abstract][Full Text] [Related]
13. Anhedonia and social adaptation predict substance abuse evolution in dual diagnosis schizophrenia.
Potvin S; Stip E; Lipp O; Roy MA; Demers MF; Bouchard RH; Gendron A
Am J Drug Alcohol Abuse; 2008; 34(1):75-82. PubMed ID: 18161645
[TBL] [Abstract][Full Text] [Related]
14. Nonadherence to antipsychotic treatment in patients with schizophrenic disorders.
Svestka J; Bitter I
Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():95-116. PubMed ID: 17262005
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology, clinical consequences, and psychosocial treatment of nonadherence in schizophrenia.
Leucht S; Heres S
J Clin Psychiatry; 2006; 67 Suppl 5():3-8. PubMed ID: 16822090
[TBL] [Abstract][Full Text] [Related]
16. Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders.
San L; Arranz B; Martinez-Raga J
Eur Addict Res; 2007; 13(4):230-43. PubMed ID: 17851245
[TBL] [Abstract][Full Text] [Related]
17. [Schizophrenia and addiction: An evaluation of the self-medication hypothesis].
Potvin S; Stip E; Roy JY
Encephale; 2003; 29(3 Pt 1):193-203. PubMed ID: 12876543
[TBL] [Abstract][Full Text] [Related]
18. Schizophrenia: attitudes of patients and professional carers towards the illness and antipsychotic medication.
Rettenbacher MA; Burns T; Kemmler G; Fleischhacker WW
Pharmacopsychiatry; 2004 May; 37(3):103-9. PubMed ID: 15138893
[TBL] [Abstract][Full Text] [Related]
19. Relapse and therapeutic interventions in a 1-year observational cohort study of nonadherent outpatients with schizophrenia.
Ciudad A; San L; Bernardo M; Olivares JM; Polavieja P; Valladares A; Gilaberte I
Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):245-50. PubMed ID: 22056291
[TBL] [Abstract][Full Text] [Related]
20. Behavioral interventions for dual-diagnosis patients.
Goldsmith RJ; Garlapati V
Psychiatr Clin North Am; 2004 Dec; 27(4):709-25. PubMed ID: 15550289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
